DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.31% to $15.83 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.77% to 20,034.89 and the Dow Jones Industrial Average falling 0.22% to 44,148.56.
Corbus Pharmaceuticals Holdings Inc. closed $46.07 below its 52-week high ($61.90), which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 1.52% to $4.67, Fortress Biotech Inc. (FBIO) fell 2.83% to $2.06, and Viking Therapeutics Inc. $(VKTX)$ rose 2.84% to $49.21.
Trading volume (347,530) remained 4,601 below its 50-day average volume of 352,131.
Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 11, 2024 17:22 ET (22:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments